158 related articles for article (PubMed ID: 16086597)
1. Short-course antimicrobial therapy for community-acquired pneumonia.
Kolditz M; Halank M; Höffken G
Treat Respir Med; 2005; 4(4):231-9. PubMed ID: 16086597
[TBL] [Abstract][Full Text] [Related]
2. How long should we treat community-acquired pneumonia?
Scalera NM; File TM
Curr Opin Infect Dis; 2007 Apr; 20(2):177-81. PubMed ID: 17496577
[TBL] [Abstract][Full Text] [Related]
3. Antimicrobial treatment of community-acquired pneumonia.
Restrepo MI; Anzueto A
Clin Chest Med; 2005 Mar; 26(1):65-73. PubMed ID: 15802167
[TBL] [Abstract][Full Text] [Related]
4. Short-course therapy for community-acquired pneumonia in paediatric patients.
Qazi S
Drugs; 2005; 65(9):1179-92. PubMed ID: 15916446
[TBL] [Abstract][Full Text] [Related]
5. Duration of antimicrobial therapy in community acquired pneumonia: less is more.
Pinzone MR; Cacopardo B; Abbo L; Nunnari G
ScientificWorldJournal; 2014; 2014():759138. PubMed ID: 24578660
[TBL] [Abstract][Full Text] [Related]
6. Antibiotic stewardship in community-acquired pneumonia.
Viasus D; Vecino-Moreno M; De La Hoz JM; Carratalà J
Expert Rev Anti Infect Ther; 2017 Apr; 15(4):351-359. PubMed ID: 28002979
[TBL] [Abstract][Full Text] [Related]
7. Severe community-acquired pneumonia in adults: current antimicrobial chemotherapy.
Niven DJ; Laupland KB
Expert Rev Anti Infect Ther; 2009 Feb; 7(1):69-81. PubMed ID: 19622058
[TBL] [Abstract][Full Text] [Related]
8. Short-course vs long-course antibiotic treatment for community-acquired pneumonia: A literature review.
Møller Gundersen K; Nygaard Jensen J; Bjerrum L; Hansen MP
Basic Clin Pharmacol Toxicol; 2019 May; 124(5):550-559. PubMed ID: 30694600
[TBL] [Abstract][Full Text] [Related]
9. Antimicrobial therapy of community-acquired pneumonia.
File TM; Niederman MS
Infect Dis Clin North Am; 2004 Dec; 18(4):993-1016, xi. PubMed ID: 15555836
[TBL] [Abstract][Full Text] [Related]
10. Community-acquired pneumonia: is it time to shorten the antibiotic treatment?
Esposito S; Fiore M
Expert Rev Anti Infect Ther; 2007 Dec; 5(6):933-8. PubMed ID: 18039078
[No Abstract] [Full Text] [Related]
11. Duration of pneumonia therapy and the role of biomarkers.
Kaziani K; Sotiriou A; Dimopoulos G
Curr Opin Infect Dis; 2017 Apr; 30(2):221-225. PubMed ID: 28079629
[TBL] [Abstract][Full Text] [Related]
12. Shortening antibiotic duration for community acquired pneumonia.
Melo L; Oliveira S
Eur J Intern Med; 2018 May; 51():e21-e22. PubMed ID: 29454484
[No Abstract] [Full Text] [Related]
13. Efficacy of 750-mg, 5-day levofloxacin in the treatment of community-acquired pneumonia caused by atypical pathogens.
Dunbar LM; Khashab MM; Kahn JB; Zadeikis N; Xiang JX; Tennenberg AM
Curr Med Res Opin; 2004 Apr; 20(4):555-63. PubMed ID: 15119993
[TBL] [Abstract][Full Text] [Related]
14. Duration and cessation of antimicrobial treatment.
File TM
J Hosp Med; 2012; 7 Suppl 1():S22-33. PubMed ID: 23677632
[TBL] [Abstract][Full Text] [Related]
15. Community acquired bacterial pneumonia.
Anevlavis S; Bouros D
Expert Opin Pharmacother; 2010 Feb; 11(3):361-74. PubMed ID: 20085502
[TBL] [Abstract][Full Text] [Related]
16. Gemifloxacin once daily for 5 days versus 7 days for the treatment of community-acquired pneumonia: a randomized, multicentre, double-blind study.
File TM; Mandell LA; Tillotson G; Kostov K; Georgiev O
J Antimicrob Chemother; 2007 Jul; 60(1):112-20. PubMed ID: 17537866
[TBL] [Abstract][Full Text] [Related]
17. [Duration of treatment and oral administrad on of antibiotics in community acquired pneumonia].
Bernal-Vargas MA; Cortés JA
Rev Chilena Infectol; 2016 Apr; 33(2):177-86. PubMed ID: 27314995
[TBL] [Abstract][Full Text] [Related]
18. Containing costs and containing bugs: are they mutually exclusive?
Nicolau DP
J Manag Care Pharm; 2009 Mar; 15(2 Suppl):S12-7. PubMed ID: 19236136
[TBL] [Abstract][Full Text] [Related]
19. Effect of a 3-step critical pathway to reduce duration of intravenous antibiotic therapy and length of stay in community-acquired pneumonia: a randomized controlled trial.
Carratalà J; Garcia-Vidal C; Ortega L; Fernández-Sabé N; Clemente M; Albero G; López M; Castellsagué X; Dorca J; Verdaguer R; Martínez-Montauti J; Manresa F; Gudiol F
Arch Intern Med; 2012 Jun; 172(12):922-8. PubMed ID: 22732747
[TBL] [Abstract][Full Text] [Related]
20. Duration of Antibiotic Treatment in Community-Acquired Pneumonia: A Multicenter Randomized Clinical Trial.
Uranga A; España PP; Bilbao A; Quintana JM; Arriaga I; Intxausti M; Lobo JL; Tomás L; Camino J; Nuñez J; Capelastegui A
JAMA Intern Med; 2016 Sep; 176(9):1257-65. PubMed ID: 27455166
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
